Bridgeway Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Buy |
202,790
+121,690
| +150% | +$417K | 0.02% | 715 |
|
|
2025
Q1 | $240K | Sell |
81,100
-24,100
| -23% | -$71.3K | 0.01% | 882 |
|
|
2024
Q4 | $321K | Buy |
105,200
+800
| +0.8% | +$2.44K | 0.01% | 908 |
|
|
2024
Q3 | $266K | Sell |
104,400
-35,000
| -25% | -$89.3K | 0.01% | 1003 |
|
|
2024
Q2 | $454K | Hold |
139,400
| – | – | 0.01% | 881 |
|
|
2024
Q1 | $739K | Buy |
139,400
+15,000
| +12% | +$79.5K | 0.02% | 826 |
|
|
2023
Q4 | $539K | Sell |
124,400
-24,000
| -16% | -$104K | 0.01% | 923 |
|
|
2023
Q3 | $390K | Hold |
148,400
| – | – | 0.01% | 949 |
|
|
2023
Q2 | $524K | Hold |
148,400
| – | – | 0.01% | 882 |
|
|
2023
Q1 | $459K | Buy |
148,400
+28,300
| +24% | +$87.4K | 0.01% | 910 |
|
|
2022
Q4 | $508K | Sell |
120,100
-6,000
| -5% | -$25.4K | 0.01% | 877 |
|
|
2022
Q3 | $299K | Hold |
126,100
| – | – | 0.01% | 1040 |
|
|
2022
Q2 | $359K | Sell |
126,100
-50,000
| -28% | -$142K | 0.01% | 954 |
|
|
2022
Q1 | $507K | Sell |
176,100
-64,613
| -27% | -$186K | 0.01% | 929 |
|
|
2021
Q4 | $732K | Buy |
+240,713
| New | +$732K | 0.01% | 870 |
|